Gefitinib: A Revolutionary EGFR Inhibitor for Cancer Treatment
Lung cancer remains one of the most aggressive and fatal cancers worldwide, with non-small cell lung cancer (NSCLC) accounting for nearly 85% of all cases. The development of targeted therapies ...
